Atrás
Precio Scinai Immunotherapeutics Ltd (SCNI)
Gráfico del Precio de Acciones SCNI
SCNI Dividendos
Scinai Immunotherapeutics Ltd
$0.86
-4.86%
$-0.04
Al cierre: Jan 16, 16:00:00 GMT-5
$0.9
4.04%
$0.03
Mercado Previo: Jan 20, 07:35:23 GMT-5
Estadísticas clave
Cierre Anterior
$0.9092
Precio de apertura
$0.954
Rango del día
$0.865 - $0.963
Rango de 52 semanas
$0.613 - $6.18
Volumen
11.3K
Volumen promedio
67.9K
EPS (TTM)
0.00
Rendimiento de dividendos
--
Cap. de mercado
$3.1M
¿Qué es SCNI?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
